TILT’s founder and CEO, Akseli Hemminki is a biotech entrepreneur and cancer clinician. He leads Tiltbio’s highly regarded and experienced team, which has grown to 20 professionals based in in Europe and the U.S., and with decades of experience in the research, development, and commercialization of cancer therapeutics.
Our Team
